NUVA logo

NuVasive (NUVA) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$248.66 M
+$2.57 M+1.05%

31 December 2022

NUVA Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Cash And Cash Equivalents

$80.72 M
-$100.48 M-55.45%

30 June 2023

NUVA Quarterly Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NUVA Cash And Cash Equivalents Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years+1.1%-67.2%
5 y5 years+16.7%-62.1%

NUVA Cash And Cash Equivalents High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time-71.0%-90.6%

NuVasive Cash And Cash Equivalents History

DateAnnualQuarterly
June 2023
-
$80.72 M(-55.5%)
Mar 2023
-
$181.20 M(-27.1%)
Dec 2022
$248.66 M(+1.0%)
$248.66 M(+4.7%)
Sept 2022
-
$237.50 M(+5.1%)
June 2022
-
$225.99 M(+10.1%)
Mar 2022
-
$205.31 M(-16.6%)
Dec 2021
$246.09 M(-71.3%)
$246.09 M(+4.9%)
Sept 2021
-
$234.58 M(+14.9%)
June 2021
-
$204.14 M(-12.7%)
Mar 2021
-
$233.86 M(-72.7%)
Dec 2020
$856.87 M(+302.2%)
$856.87 M(+10.6%)
Sept 2020
-
$774.54 M(-2.8%)
June 2020
-
$796.77 M(+55.6%)
Mar 2020
-
$511.98 M(+140.3%)
Dec 2019
$213.03 M(+80.8%)
$213.03 M(+30.4%)
Sept 2019
-
$163.40 M(+27.3%)
June 2019
-
$128.38 M(+37.5%)
Mar 2019
-
$93.39 M(-20.7%)
Dec 2018
$117.84 M(+61.9%)
$117.84 M(+56.9%)
Sept 2018
-
$75.11 M(+7.2%)
June 2018
-
$70.08 M(-5.0%)
Mar 2018
-
$73.74 M(+1.3%)
Dec 2017
$72.80 M(-52.6%)
$72.80 M(+17.0%)
Sept 2017
-
$62.20 M(-52.5%)
June 2017
-
$130.93 M(-2.3%)
Mar 2017
-
$134.01 M(-12.8%)
Dec 2016
$153.64 M(-20.1%)
$153.64 M(-24.6%)
Sept 2016
-
$203.82 M(-22.5%)
June 2016
-
$263.08 M(-2.6%)
Mar 2016
-
$270.11 M(+40.4%)
Dec 2015
$192.34 M(+35.1%)
$192.34 M(+36.1%)
Sept 2015
-
$141.33 M(+79.7%)
June 2015
-
$78.64 M(-11.1%)
Mar 2015
-
$88.49 M(-37.8%)
Dec 2014
$142.39 M(+38.5%)
$142.39 M(+9.0%)
Sept 2014
-
$130.66 M(+22.7%)
June 2014
-
$106.46 M(-3.9%)
Mar 2014
-
$110.78 M(+7.7%)
Dec 2013
$102.83 M
$102.83 M(+2.2%)
Sept 2013
-
$100.62 M(+70.9%)
DateAnnualQuarterly
June 2013
-
$58.88 M(-25.0%)
Mar 2013
-
$78.47 M(-36.4%)
Dec 2012
$123.30 M(-24.6%)
$123.30 M(+14.5%)
Sept 2012
-
$107.73 M(-11.1%)
June 2012
-
$121.16 M(-55.2%)
Mar 2012
-
$270.18 M(+65.3%)
Dec 2011
$163.49 M(+76.6%)
$163.49 M(-26.0%)
Sept 2011
-
$220.94 M(-56.3%)
June 2011
-
$505.08 M(+276.6%)
Mar 2011
-
$134.10 M(+44.8%)
Dec 2010
$92.60 M(+41.6%)
$92.60 M(+31.2%)
Sept 2010
-
$70.59 M(+4.6%)
June 2010
-
$67.51 M(-13.1%)
Mar 2010
-
$77.66 M(+18.7%)
Dec 2009
$65.41 M(-50.6%)
$65.41 M(-51.3%)
Sept 2009
-
$134.28 M(-1.5%)
June 2009
-
$136.33 M(-5.8%)
Mar 2009
-
$144.76 M(+9.4%)
Dec 2008
$132.32 M(+113.7%)
$132.32 M(+26.8%)
Sept 2008
-
$104.39 M(-23.4%)
June 2008
-
$136.22 M(-47.3%)
Mar 2008
-
$258.53 M(+317.6%)
Dec 2007
$61.91 M(+49.3%)
$61.91 M(+9.9%)
Sept 2007
-
$56.34 M(+27.4%)
June 2007
-
$44.22 M(+18.2%)
Mar 2007
-
$37.40 M(-9.8%)
Dec 2006
$41.48 M(+230.6%)
$41.48 M(-20.8%)
Sept 2006
-
$52.36 M(-48.7%)
June 2006
-
$102.06 M(-5.3%)
Mar 2006
-
$107.76 M(+759.0%)
Dec 2005
$12.54 M(+46.6%)
$12.54 M(+39.1%)
Sept 2005
-
$9.02 M(+74.3%)
June 2005
-
$5.17 M(-68.4%)
Mar 2005
-
$16.37 M(+91.3%)
Dec 2004
$8.56 M(+52.0%)
$8.56 M(-53.1%)
Sept 2004
-
$18.24 M(-37.1%)
June 2004
-
$28.99 M(+288.8%)
Mar 2004
-
$7.46 M
Dec 2003
$5.63 M(-18.5%)
-
Dec 2002
$6.91 M
-

FAQ

  • What is NuVasive annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for NuVasive?
  • What is NuVasive quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for NuVasive?

What is NuVasive annual cash & cash equivalents?

The current annual cash & cash equivalents of NUVA is $248.66 M

What is the all time high annual cash & cash equivalents for NuVasive?

NuVasive all-time high annual cash & cash equivalents is $856.87 M

What is NuVasive quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of NUVA is $80.72 M

What is the all time high quarterly cash and cash equivalents for NuVasive?

NuVasive all-time high quarterly cash and cash equivalents is $856.87 M